Table 2.
List of analyte targets detected by fluorescence-based sensors.
| Analyte | Method | Sensing Element/Fluorescent Molecules | LoD/Dynamic Range | Ref. |
|---|---|---|---|---|
| Food | ||||
| Penicillin G | FP | Antibody/NIR-CF647 | 1.0 nmol/L | [134] |
| Ciprofloxacin | FP | Antibody/NIR-CF647 | 1 ppb | [135] |
| Amikacin | FS | Enzyme/fluorescein-5 maleimide | 40 nM | [122] |
| Kanamycin A | FS | Enzyme/fluorescein-5 maleimide | 50 nM | [122] |
| Gentamicin | FS | Enzyme/fluorescein-5 maleimide | 10 nM | [122] |
| Neomycin | FS | Enzyme/fluorescein-5 maleimide | 7 nM | [122] |
| Tobramycin | FS | Enzyme/fluorescein-5 maleimide | 5 nM | [122] |
| Paromomycin | FS | Enzyme/fluorescein-5 maleimide | 10 nM | [122] |
| Fluoroquinolone | FP | Antibody/nanoparticles | 0.1 nM | [123] |
| Sulfadimethoxine | FI | Aptamer/fluorescein amidite | 10 ng/mL | [124] |
| Chloramphenicol | TR-FIA | Antibody/europium | 0.05 ng g−1 | [130] |
| Fluoroquinolone | TR-FIA | Antibody/Europium | 0.053 μg/L | [131] |
| Patulin | FP | Antibody/NIR DyLight IF800 | 0.06 μg/L | [136] |
| Ochratoxin A | FCS | Antibody/FITC | 0.0078 ng | [137] |
| 17β-estradiol | FP | Antibody/CF647 | <10 pmol | [140] |
| Hexestrol | FP | Receptor/coumestrol | 2.94 nM | [141] |
| Dienestrol | FP | Receptor/coumestrol | 2.89 nM | [141] |
| Diethylstilbestrol | FP | Receptor/coumestrol | 3.12 nM | [141] |
| α-lactalbumins | FLISA | Antibody/CdSe/ZnS quantum dots | 0.1 ng/mL | [142] |
| Lactoferrin | FP | Aptamer/FITC and Ag10NPs | 1.25 pM | [143] |
| Gluten | FCS | Antibody/FITC | 0.006 ppm | [144] |
| Environment | ||||
| Testosterone | TIRF | Antibody | 0.2 ng/L | [147] |
| Carbaryl | FI | Enzyme/silicon quantum dots (SiQDs) | 7.25 × 10−9 g/L | [155] |
| Parathion | FI | Enzyme/silicon quantum dots (SiQDs) | 3.25 × 10−8 g/L | [155] |
| diazinon | FI | Enzyme/silicon quantum dots (SiQDs) | 6.76 × 10−8 g/L | [155] |
| Phorate | FI | Enzyme/silicon quantum dots (SiQDs) | 1.90 × 10−7 g/L | [155] |
| Acetylcholinesterase | FI | Enzyme/nanoclusters DNA-Cu/AgNCs | 0.05 U/mL | [157] |
| Acetylcholinesterase | FI | Enzyme/nanoclusters AuNCs | 2.0 × 10−6 U/mL | [158] |
| DDVP | FI | Enzyme/nanoclusters AuNCs | 13.67 pM | [158] |
| Benzene | FRET | Protein/ 1-aminoanthracene | 3.9 μg/m3 | [160] |
| Security | ||||
| Ricin A | FI | Protein/AuNCs | 400 nM | [164] |
| Bacillus anthracis | FI | Antibody/silicon nitride surfaces | 103 CFU/mL | [165] |
| Health | ||||
| IL-1β | FI | Antibody/FITC | 8.91 pg/mL | [172] |
| IL-6 | FI | Antibody/FITC | 1.33 pg/mL | [172] |
| IL-10 | FI | Antibody/FITC | 6.12 pg/mL | [172] |
| Dopamine | FI | Bi-functionalized carbon dots | 0.1 pM | [176] |
| 17β-estradiol | FI | Aptamer/fluorescent dye | 2.1 nM | [177] |
| 17β-estradiol | FI | Antibody/nanoparticles DC-AuNPs | 6.4 × 10−6 ng/mL | [178] |
| Calcium ion | FI | Turn-on fluorescent probe | 2.70 × 10−7 M | [196] |
| Calcium ion | FI | Receptor/mIFP | 0.01 to 1 μM a | [191] |
| Calcium ion | FI | Receptor/GAF-sfGFP | 0.1 to 5 μM a | [193] |
| Calcium ion | FI | Receptor/cpFAST | 0.04 to 0.2 μM a | [194] |
| Hg2+ | FI | NIR-activatable probe-HCy−SeH | 10 to 60 μM a | [199] |
| Hg2+ | FI | BPs (IFP1.4) | 32 μM | [201] |
| MeHg+ | LRET | UCNPs/UCL | 0.18 ppb | [200] |
| O2- | FI | NIR-activatable probe-HCy−SeH | 10 to 60 μM a | [199] |
| NAD+ | FI | Enzyme/cpVenus | 30 μM to 1 mM a | [206] |
| NAD+ | FI | Enzyme/cpYFP | 0.1 to 10 mM a | [207] |
| NAD+ | BRET | Enzyme-cpLuc/Cy3 | 10−4 to 10−8 M a | [208] |
| Acetylcholine | FI | Receptor/cpEGFP | 10 nM to 100 μM a | [209] |
| Dopamine | FI | Receptor/cpEGFP | 10−6 to 10−8 M a | [210] |
| Epinephrine | FI | Receptor/cpEGFP | 10−6 to 10−8 M a | [211] |
| H2O2 | FI | Enzyme/NeonOxIrr | pH 5.5 to 7.5 a | [192] |
| Nitric Oxide | FRET | FITC and DABCYL | 100 pM to 5 nM a | [216] |
| hydrogen ion | FI | Pentamethine cyanine fluorophores | pH 1.0 to 4.0 a | [227] |
a The working dynamic range values are reported for in vivo biosensors.